Lack of interaction between tramadol and coumarins

Journal of Clinical Pharmacology

Volumn 38, Issue 10, 1998, Pages 966-970

  Boeijinga, Johan K ^a   Van Meegen, Erik ^b   Van Den Ende, Romana ^c   Schook, C Edward ^c   Cohen, Adam F ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Thrombosis Service's Gravenhage   (Netherlands)

^c Byk Nederland BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; COUMARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENPROCOUMON; PROTHROMBIN; TRAMADOL;

ADULT; AGED; ANALGESIA; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MONITORING; FEMALE; HUMAN; HYPOPROTHROMBINEMIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THROMBOSIS;

EID: 0031759435     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04394.x     Document Type: Article

References (35)

1. Koch-Weser J, Sellers EM: Drug interactions with coumarin anticoagulants. New Engl J Med 1971;285:487-498.
2. Koch-Weser J, Sellers EM: Drug interactions with coumarin anticoagulants. New Engl J Med 1971;285:547-558.
3. Boeijinga JK, van der Vijgh WJF: Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar). Eur J Clin Pharmacol 1977;12:291-296.
4. Caron J, Libersa C, Thomas C: Drugs affecting blood clotting, fibrinolysis, and hemostasis. In, Dukes MNG (ed.): Meyler's Side Effects of Drugs. Thirteenth edition. Amsterdam: Elsevier Science, 1998, 1008-1055.
5. Harder S, Thürmann P: Clinically important drug interactions with anticoagulants: an update. Clin Pharmacokinet 1996; 30:416-444.
6. Johnson AG, Seidemann P, Day RO: NSAID-related adverse drug interactions with clinical relevance. Int J Clin Pharmacol Ther 1994;32:509-532.
7. Brouwers JRBJ, de Smet PAGM: Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1994;27:462-485.
8. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE: Acetaminophen and other risk facors for excessive warfarin anticoagulation. JAMA 1998;279:657-662.
9. Bell WR: Acetaminophen and warfarin: undesirable synergy. JAMA 1998;279:702-703.
10. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL: Opioid and nonopiod components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther 1992;260:275-285.
11. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, et al: Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993;267:331-340.
12. Raffa RB, Friderichs E: The basic science aspect of tramadol hydrochloride. Pain Rev 1996;3:249-271.
13. Desmeules JA, Piguet V, Collart L, Dayer P: Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996;41:7-12.
14. Lintz W, Barth H, Osterloh G, Schmidt-Böthelt E: Bioavailability of enteral tramadol formulations, first communication: capsules. Arzneimittelforschung 1986;36:1278-1283.
15. Raffa RB, Nayak RK, Liao S, Minn FL: The mechanism(s) of action and pharmacokintics of tramadol hydrochloride. Rev Contemp Pharmacother 1995:6:485-497.
16. Lintz W, Erlaçin S, Frankus E, Uragg H: Biotransformation of tramadol in man and animal. Arzneimittelforschung 1981; 31:1932-1943.
17. Lee CR, McTavish D, Sorkin EM: Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993:46:313-340.
18. Poulsen L, Arendt-Nielsen L, Brøsen K, Sindrup SH: The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharmacol Ther 1996;60:636-644.
19. Paar WD, Frankus P, Dengler HJ: The metabolism of tramadol by human liver microsomes. Clin Invest 1992;70:708-710.
20. Slaughter RL, Edwards DJ: Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995;29:619-624.
21. Rodrigues N, Rodrigues Pereira E: Tramadol in cancer pain. Curr Ther Res 1989;46:1142-1148.
22. Vickers MD: The efficacy of tramadol hydrochloride in the treatment of postoperative pain. Rev Contemp Pharmacother 1995;6:499-506.
23. Budd K: The efficacy of tramadol hydrochloride in the treatment of acute and chronic pain. Rev Contemp Pharmacother 1995;6:507-512.
24. Jensen EM, Ginsberg F: Tramadol versus dextropropoxyphene in the treatment of osteoarthritis. Drug Invest 1994;8:211-218.
25. Steinijans VW, Hartmann M, Huber R, Radtke HW: Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol 1991;29:323-328.
26. Ehrlich A, Fuder H, Hartmann M, Wieckhorst G, Timmer W, Huber R, et al: Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man. Eur J Clin Pharmacol 1996;51:277-281.
27. Boeijinga JJ, Boerstra EE, Ris P, Breimer DD, Jeletich-Bastiaanse A: Interaction between paracetamol and coumarin anticoagulants (letter). Lancet 1982;1:506.
28. Patrono C: Aspirin as an antiplatelet drug. New Engl J Med 1994;330:1287-1294.
29. Lin JH, Cocchetto D, Duggan DE: Protein binding as a primary determinant of the clinical pharmacokinetic properties of nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1987;12: 402-432.
30. Diana FJ, Veronich K, Kapoor AL: Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin. J Pharm Sci 1989;78:195-199.
31. Banfield C, O'Reilly R, Chan E, Rowland M: Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. Br J Clin Pharmacol 1983;16:669-675.
32. Rothschild BM: Hematologic perturbations associated with salicylate. Clin Pharmacol Ther 1979:26:145-152.
33. Madsen H, Møller Rasmussen J, Brøsen K: Interaction between tramadol and phenprocoumon (letter). Lancet 1997:350: 637.
34. Boeijinga JK, van Meegen E, van den Ende R, Schook CE, Cohen AF: Is there interaction between tramadol and phenprocoumon? (letter). Lancet 1997;350:1552.
35. Scher ML, Huntington NH, Vitillo JA: Potential interaction between tramadol and warfarin (letter). Ann Pharmacother 1997; 31:646-647.